- Home
- RBRK vs SNN Comparison
RBRK vs SNN Comparison
Compare RBRK & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBRK
- SNN
- Stock Information
- Founded
- RBRK 2013
- SNN 1856
- Country
- RBRK United States
- SNN United Kingdom
- Employees
- RBRK N/A
- SNN N/A
- Industry
- RBRK
- SNN Industrial Specialties
- Sector
- RBRK
- SNN Health Care
- Exchange
- RBRK NYSE
- SNN Nasdaq
- Market Cap
- RBRK 11.9B
- SNN 12.3B
- IPO Year
- RBRK 2024
- SNN 1999
- Fundamental
- Price
- RBRK $61.61
- SNN $25.93
- Analyst Decision
- RBRK Strong Buy
- SNN Hold
- Analyst Count
- RBRK 20
- SNN 3
- Target Price
- RBRK $70.56
- SNN $27.00
- AVG Volume (30 Days)
- RBRK 3.1M
- SNN 1.2M
- Earning Date
- RBRK 06-10-2025
- SNN 02-25-2025
- Dividend Yield
- RBRK N/A
- SNN 2.89%
- EPS Growth
- RBRK N/A
- SNN 56.15
- EPS
- RBRK N/A
- SNN 0.47
- Revenue
- RBRK $886,544,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- RBRK $33.44
- SNN $6.42
- Revenue Next Year
- RBRK $24.85
- SNN $5.03
- P/E Ratio
- RBRK N/A
- SNN $27.69
- Revenue Growth
- RBRK 41.19
- SNN 4.70
- 52 Week Low
- RBRK $28.34
- SNN $23.65
- 52 Week High
- RBRK $80.00
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- RBRK N/A
- SNN 41.26
- Support Level
- RBRK N/A
- SNN $25.63
- Resistance Level
- RBRK N/A
- SNN $26.32
- Average True Range (ATR)
- RBRK 0.00
- SNN 0.74
- MACD
- RBRK 0.00
- SNN -0.13
- Stochastic Oscillator
- RBRK 0.00
- SNN 41.06
About RBRK RUBRIK INC
Rubrik Inc is a company that offers data security solutions to organizations ranging from the largest companies worldwide to mid-sized smaller customers. Its platform is architected to help organizations achieve cyber resilience, which encompasses cyber posture and cyber recovery. They enable organizations to confidently accelerate digital transformation and leverage the cloud to realize business agility.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.